Click me

Biosimilars market to hit $35 billion by 2020, research suggests

Global Biosimilars/Follow-on-Biologics Market By Geography Global Biosimilars/Follow-on-Biologics Market 2020 $35.032 Billion 2019 Growing at 2018 North America,Europe, LAMEA a CAGR of 2017 60.8% Asia-Pacific $1.110 Billion 2016 Highest Revenue Generating Geography By 2020 2015 (2014 - 2020) 2014 2013 $1.358 Billion Global Biosimilars/Follow-on-Biologics Market By Product Type Global Biosimilars/ Follow-on-Biologics Recombinant Non-Glycosylated Protein Recombinant Glycosylated Proteins Peptides Market Insulin Monoclonal antibodies Octreotide Effective treatment for chronic diseases and growth-related deficiencies - a top driving factor. Interferon Erythropoietin Desmopressin Minimal side Human Growth Hormone Capabilities to treat life threatening, rare and deep-rooted infirmities – a factor that is impelling the market. Cyclosporine effects, better than (Technology, Types, Applications, Services and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 Granulocyte colony-stimulating factors Calcitonin combinational drugs, effective treatment for others Eptifibatide LH-RH (Leuprolide) oncology Nesiritide Global Biosimilars/Follow-on-Biologics Market By Services Teriparatide Bivalirudin Contract Research and Manufacturing Services(CRMS) Glucagon Clinical trials Enfuvirtide Global Biosimilars/Follow-on-Biologics Market By Applications Global Biosimilars/Follow-on-Biologics Market By Technology Percentage Share According to CAGR Monoclonal Antibodies (MAb) Technology Manifold applications of biosimilars, especially Electrophoresis Chronic and for oncology, Autoimmune diseases Low-priced therapeutics Recombinant DNA Technology (rDNA technology) and evolving patent Fastest growing segment garnering about 23% of the total conditions are the Mass Spectrometry paramount factors for For More Details the propelling market. Chromatography Visit Us at CAGR Western Blotting Blood Disorders Chronic and Nuclear magnetic resonance (NMR) technology arket IResearch Oncology diseases Autoimmune diseases Diligent Intelligence - Improved Growth, Bioassay ©Allied Market Research Others GH deficiency

Biosimilars market to hit $35 billion by 2020, research suggests

shared by alliedmarketresearch on Aug 05
Global biosimilars/follow-on-biologics market accounted for $1,358 million in 2013 and it is anticipated to generate $35,032 million by 2020, growing at a CAGR of 60.8% from 2014 to 2020.


Ajit Ingale


Did you work on this visual? Claim credit!

Get a Quote

Embed Code

For hosted site:

Click the code to copy


Click the code to copy
Customize size